Join to View Full Profile
43 Rock LnBerkeley, CA 94708
Phone+1 415-572-8437
Dr. Skarbinski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Emory University School of MedicineFellowship, Infectious Disease, 2007 - 2010
University of California (San Francisco)Residency, Internal Medicine, 2001 - 2004
Stanford University School of MedicineClass of 2001
Certifications & Licensure
CA State Medical License 2016 - 2026
GA State Medical License 2007 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in Malawi Start of enrollment: 2010 Mar 01
- Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi Start of enrollment: 2011 Aug 01
Publications & Presentations
PubMed
- In the time of COVID-19: challenges, successes and lessons learned from studies in cancer patients.Philip C Mack, James M Crawford, Andres Chang, Anna Yin, Sabra L Klein
Journal of the National Cancer Institute. 2025-03-24 - Risk of Incident Tuberculosis Disease in a Large Integrated Health Care System in California, 2004-2022.Jacek Skarbinski, Yuching Ni, Nicole Halmer, Katia J Bruxvoort, Joshua R Nugent
Open Forum Infectious Diseases. 2025-03-01 - Contribution of Post-TB Sequelae to Life-Years Lost from TB Disease in the United States, 2015-2019.Nicolas A Menzies, Suzanne M Marks, Yuli L Hsieh, Nicole A Swartwood, Garrett R Beeler Asay
American Journal of Respiratory and Critical Care Medicine. 2025-02-10
Press Mentions
Researchers Explore COVID-19 Genome for Clues to Virus BehaviorFebruary 25th, 2025- Here Are the Latest Updates on Coronavirus Treatments and the Moderna, Pfizer and Other VaccinesNovember 29th, 2020
- Efforts at Coronavirus Vaccines and Treatments Abound in the Bay AreaJune 22nd, 2020
- Join now to see all
Grant Support
- SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical UseKAISER FOUNDATION RESEARCH INSTITUTE2020–2025
- SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical UseKAISER FOUNDATION RESEARCH INSTITUTE2024
- SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical UseKAISER FOUNDATION RESEARCH INSTITUTE2024
- SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical UseKAISER FOUNDATION RESEARCH INSTITUTE2024
- SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical UseKAISER FOUNDATION RESEARCH INSTITUTE2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
